New Delhi, India (PressExposure) May 21, 2009 -- Q4 Highlights
â¢ Positive top line growth for the quarter. Revenue of $4.11 billion, down 8.3% (up 0.4% in constant currency) over same quarter last year
â¢ Operating income of $447 million, net income of $382 million EPS of $2.51 including $1.11 of tax benefits and a goodwill impairment charge of $0.12.
â¢ Record breaking free cash flow of $850 million
â¢ Operating margin of 10.9%, a 85 basis-point improvement over the prior year.
â¢ $3.5 billion in new bookings for the quarter
FY09 Full Year Highlights
â¢ Positive top line growth for FY09. Revenue of $16.74 billion, up 1.5% (up 4.3% in constant currency) year over year (slightly below guidance)
â¢ Net income of $1,115million
â¢ Operating margin of 8.25%, a year-over-year improvement of 27 basis points
â¢ EPS of $7.31 including $3.36 of tax benefits and a goodwill impairment charge of $0.12, meeting guidance
â¢ Free cash flow of $1,021 million, compared with $175 million in FY08
â¢ Revenue growth by industry vertical compared to last year, in constant currency: - Healthcare, up 30% PS up 4%, FSS flat, CENR up 5% and MFG up 2%
- TCM down 2%
â¢ By lines of business, CSC reported revenues of:
- $4.41 billion for BS&S, up 11.9% year over year in constant currency - $6.46 billion for GOS, up 0.3% year over year in constant currency - $5.98 billion for NPS, up 3.4% year over year in constant currency
â¢ New bookings of $16.2 billion, slightly below guidance, a 4% increase over last year
- $7.3 billion from NPS - $4.5 billion from BS&S - $4.4 billion from GOS
â¢ Successful execution and delivery of all NHS key milestones and receipt of associated payments
â¢ Remediation of material weakness associated with tax accounting
â¢ FY10Guidance/Outlook: Revenue in the $16 - $16.5 billion range and EPS in the $4.20 to $4.30 per share range, and free cash flow to be in a range of 90%-100% of net income.